Format

Send to

Choose Destination
F1000Res. 2017 Mar 17;6:288. doi: 10.12688/f1000research.10992.1. eCollection 2017.

Resistance mechanisms to drug therapy in breast cancer and other solid tumors: An opinion.

Author information

1
St Petersburg Academic University, St. Petersburg, 194021, Russian Federation.
2
St. Petersburg Clinical Research and Practical Center for Specialized Types of Medical Care (Oncologic), St. Petersburg, 197758, Russian Federation.
3
Peter the Great St. Petersburg Polytechnic University, St. Petersburg, 195251, Russian Federation.
4
The Petersburg Nuclear Physics Institute, Gatchina, 88300, Russian Federation.

Abstract

Cancer is an important contributor to mortality worldwide. Breast cancer is the most common solid tumor in women. Despite numerous drug combinations and regimens, all patients with advanced breast cancer, similarly to other solid tumors, inevitably develop resistance to treatment. Identified mechanisms of resistance could be classified into intra- and extracellular mechanisms. Intracellular mechanisms include drug metabolism and efflux, target modulations and damage restoration. Extracellular mechanisms might be attributed to the crosstalk between tumor cells and environmental factors. However, current knowledge concerning resistance mechanisms cannot completely explain the phenomenon of multi-drug resistance, which occurs in the vast majority of patients treated with chemotherapy. In this opinion article, we investigate the role of these factors in the development of drug-resistance.

KEYWORDS:

breast cancer; cancer; chemotherapy; resistance

Conflict of interest statement

Competing interests: No competing interests were disclosed.

Supplemental Content

Full text links

Icon for F1000 Research Ltd Icon for PubMed Central
Loading ...
Support Center